Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sanofi SA (NYSE:SNY)

37.83
Delayed Data
As of Sep 29
 -0.84 / -2.17%
Today’s Change
37.41
Today|||52-Week Range
51.88
-11.30%
Year-to-Date
Why Investors Are Paying a Premium for Regeneron Pharmaceuticals, Inc.
Sep 29 / MotleyFool.com - Paid Partner Content
3 Critical FDA Decisions You Can't Afford to Miss
Sep 27 / MotleyFool.com - Paid Partner Content
The Highest-Yielding Drug Stocks
Sep 29 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Teva Pharmaceutical Industries, Intel, Sanofi, Alp...
Sep 27 / Zacks.com - Paid Partner Content
Novo Nordisk Takes Axe to Workforce as Growth Falters
Sep 29 / TheStreet.com - Paid Partner Content
Biosimilars in Limelight on FDA Approval of Amgen Drug
Sep 27 / Zacks.com - Paid Partner Content
3 Top Dividend Stocks Selling for a Discount This Fall
Sep 28 / MotleyFool.com - Paid Partner Content
Regeneron, Sanofi Skin Disease Drug Under Priority Review
Sep 26 / Zacks.com - Paid Partner Content
3 Stocks to Avoid in Healthcare
Sep 28 / MotleyFool.com - Paid Partner Content
The Internet of Medical Things: 6 Stocks in Focus
Sep 26 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.67
Today’s open38.39
Day’s range37.71 - 38.48
Volume7,285,157
Average volume (3 months)2,356,019
Market cap$99.5B
Dividend yield4.40%
Data as of 4:02pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)-17.98%
Earnings growth (this year)--
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)-14.57%
P/E ratio23.8
Price/Sales2.96
Price/Book1.58

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie-1.40-2.18%
AGNAllergan-6.99-2.94%
GSKGlaxoSmithKline-0.77-1.76%
BMYBristol-Myers Squibb-1.22-2.21%
Data as of 4:05pm ET, 09/29/2016

Financials

Next reporting dateOctober 28, 2016
EPS forecast (this quarter)$0.87
Annual revenue (last year)$38.1B
Annual profit (last year)$4.7B
Net profit margin12.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
EVP-Finance
Jérôme Contamine
Corporate headquarters
Paris, Ile-de-france

Forecasts

Search for Jobs